Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

A genomic screen identifies TYRO3 as a MITF regulator in melanoma.

Zhu S, Wurdak H, Wang Y, Galkin A, Tao H, Li J, Lyssiotis CA, Yan F, Tu BP, Miraglia L, Walker J, Sun F, Orth A, Schultz PG, Wu X.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17025-30. doi: 10.1073/pnas.0909292106. Epub 2009 Sep 23.

2.

Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.

Kido K, Sumimoto H, Asada S, Okada SM, Yaguchi T, Kawamura N, Miyagishi M, Saida T, Kawakami Y.

Cancer Sci. 2009 Oct;100(10):1863-9. doi: 10.1111/j.1349-7006.2009.01266.x. Epub 2009 Jun 29.

3.

NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.

Kim A, Yang Y, Lee MS, Yoo YD, Lee HG, Lim JS.

Pigment Cell Melanoma Res. 2008 Dec;21(6):653-64. doi: 10.1111/j.1755-148X.2008.00503.x.

PMID:
19067970
4.

TYRO3-mediated regulation of MITF: a novel target in melanoma?

Rudloff U, Samuels Y.

Pigment Cell Melanoma Res. 2010 Feb;23(1):9-11. doi: 10.1111/j.1755-148X.2009.00649.x. Epub 2009 Oct 20. No abstract available.

5.

BPTF transduces MITF-driven prosurvival signals in melanoma cells.

Dar AA, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M, De Semir D, Sagebiel RW, Miller JR 3rd, Debs R, Cleaver JE, Kashani-Sabet M.

Proc Natl Acad Sci U S A. 2016 May 31;113(22):6254-8. doi: 10.1073/pnas.1606027113. Epub 2016 May 16.

6.

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.

Nature. 2005 Jul 7;436(7047):117-22.

7.

MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.

Ondrušová L, Vachtenheim J, Réda J, Záková P, Benková K.

PLoS One. 2013;8(1):e54110. doi: 10.1371/journal.pone.0054110. Epub 2013 Jan 17.

8.

Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Keenen B, Qi H, Saladi SV, Yeung M, de la Serna IL.

Oncogene. 2010 Jan 7;29(1):81-92. doi: 10.1038/onc.2009.304. Epub 2009 Sep 28.

9.

Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray.

Villareal MO, Han J, Ikuta K, Isoda H.

J Dermatol Sci. 2012 Jul;67(1):26-36. doi: 10.1016/j.jdermsci.2012.04.005. Epub 2012 Apr 19.

PMID:
22564683
10.

GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.

Javelaud D, Alexaki VI, Pierrat MJ, Hoek KS, Dennler S, Van Kempen L, Bertolotto C, Ballotti R, Saule S, Delmas V, Mauviel A.

Pigment Cell Melanoma Res. 2011 Oct;24(5):932-43. doi: 10.1111/j.1755-148X.2011.00893.x. Epub 2011 Aug 18.

PMID:
21801332
11.

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.

Giuliano S, Cheli Y, Ohanna M, Bonet C, Beuret L, Bille K, Loubat A, Hofman V, Hofman P, Ponzio G, Bahadoran P, Ballotti R, Bertolotto C.

Cancer Res. 2010 May 1;70(9):3813-22. doi: 10.1158/0008-5472.CAN-09-2913. Epub 2010 Apr 13.

12.

A role for ATF2 in regulating MITF and melanoma development.

Shah M, Bhoumik A, Goel V, Dewing A, Breitwieser W, Kluger H, Krajewski S, Krajewska M, Dehart J, Lau E, Kallenberg DM, Jeong H, Eroshkin A, Bennett DC, Chin L, Bosenberg M, Jones N, Ronai ZA.

PLoS Genet. 2010 Dec 23;6(12):e1001258. doi: 10.1371/journal.pgen.1001258.

13.

Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.

Sestáková B, Ondrusová L, Vachtenheim J.

Pigment Cell Melanoma Res. 2010 Apr;23(2):238-51. doi: 10.1111/j.1755-148X.2010.00670.x. Epub 2010 Jan 7.

PMID:
20067556
14.

Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.

Vachtenheim J, Novotná H.

Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):1075-82.

PMID:
10644012
15.

miR-148 regulates Mitf in melanoma cells.

Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E.

PLoS One. 2010 Jul 14;5(7):e11574. doi: 10.1371/journal.pone.0011574.

16.

Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.

Fernández-Barral A, Orgaz JL, Baquero P, Ali Z, Moreno A, Tiana M, Gómez V, Riveiro-Falkenbach E, Cañadas C, Zazo S, Bertolotto C, Davidson I, Rodríguez-Peralto JL, Palmero I, Rojo F, Jensen LD, del Peso L, Jiménez B.

Neoplasia. 2014 Jun;16(6):529-42. doi: 10.1016/j.neo.2014.06.001. Epub 2014 Jul 13.

17.

PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.

Grabacka M, Placha W, Urbanska K, Laidler P, Płonka PM, Reiss K.

Pigment Cell Melanoma Res. 2008 Jun;21(3):388-96. doi: 10.1111/j.1755-148X.2008.00460.x. Epub 2008 Apr 26.

18.
19.

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.

Cheli Y, Giuliano S, Botton T, Rocchi S, Hofman V, Hofman P, Bahadoran P, Bertolotto C, Ballotti R.

Oncogene. 2011 May 19;30(20):2307-18. doi: 10.1038/onc.2010.598. Epub 2011 Jan 31. Erratum in: Oncogene. 2011 May 19;30(20):2390. Guiliano, S [corrected to Giuliano, S].

PMID:
21278797
20.

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.

Sensi M, Catani M, Castellano G, Nicolini G, Alciato F, Tragni G, De Santis G, Bersani I, Avanzi G, Tomassetti A, Canevari S, Anichini A.

J Invest Dermatol. 2011 Dec;131(12):2448-57. doi: 10.1038/jid.2011.218. Epub 2011 Jul 28.

Supplemental Content

Support Center